Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 74.37B | 71.01B | 66.17B | 66.72B | 53.05B | 54.87B |
Gross Profit | 71.11B | 0.00 | 66.17B | 66.72B | 53.05B | 54.87B |
EBITDA | 9.89B | 6.26B | 10.46B | 0.00 | 8.62B | 0.00 |
Net Income | 8.36B | 7.55B | 6.54B | 5.41B | 5.38B | 3.62B |
Balance Sheet | ||||||
Total Assets | 4.54T | 4.51T | 4.55T | 4.32T | 4.31T | 3.81T |
Cash, Cash Equivalents and Short-Term Investments | 803.47B | 0.00 | 872.90B | 725.87B | 942.67B | 512.69B |
Total Debt | 613.77B | 648.98B | 402.20B | 388.76B | 430.65B | 229.80B |
Total Liabilities | 4.33T | 4.30T | 4.34T | 4.14T | 4.11T | 3.61T |
Stockholders Equity | 214.48B | 208.49B | 217.81B | 187.45B | 198.00B | 202.68B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 43.54B | 12.02B | -98.87B | 468.91B | 339.46B |
Operating Cash Flow | 0.00 | 45.06B | 13.54B | -95.94B | 470.28B | 341.52B |
Investing Cash Flow | 0.00 | -86.63B | 15.39B | -120.08B | -34.18B | -165.66B |
Financing Cash Flow | 0.00 | -50.35B | 77.83B | -1.26B | -1.19B | -1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | 77.46B | 7.41 | 5.16% | 2.38% | 14.57% | 45.13% | |
72 Outperform | 52.24B | 11.93 | 3.25% | 2.65% | -12.00% | 28.81% | |
70 Outperform | 869.70B | 11.48 | ― | 2.98% | 10.63% | 12.90% | |
63 Neutral | $75.74B | 10.35 | 3.53% | 2.21% | 2.61% | -1.50% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |